TGFB1 and cancer: They found that miR-130b-3p inhibits DEPDC1 expression, which, via the TGF-β signalling pathway, leads to reduced proliferation, migration, and apoptosis suppression in cancer cells; additionally, a decrease in serum exosomal miR-130b-3p was noted in NSCLC patients.